BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2914487)

  • 1. Unconjugated pteridines in bronchoalveolar lavage as indicators of alveolar macrophage activation.
    Dhondt JL; Darras A; Mulliez P; Hayte JM; Crinquette J
    Chest; 1989 Feb; 95(2):348-51. PubMed ID: 2914487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferation of alveolar macrophages in pulmonary sarcoidosis correlates with markers of lymphocyte activity in bronchoalveolar lavage fluid].
    Barth J; Kreipe H; Kiemle-Kallee J; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():224-5. PubMed ID: 1973297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.
    Homolka J; Lorenz J; Zuchold HD; Müller-Quernheim J
    Clin Investig; 1992 Oct; 70(10):909-16. PubMed ID: 1280495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum neopterin and lymphocytic alveolitis in sarcoidosis.
    Blaschke E; Eklund A; Persson U
    Sarcoidosis; 1988 Mar; 5(1):25-30. PubMed ID: 2837821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated local production of neopterin from alveolar macrophages in patients with internal lung diseases.
    Saito M; Chihara J; Mouri T; Kurachi D; Yamamoto T; Nakajima S
    Gen Pharmacol; 1996 Apr; 27(3):483-6. PubMed ID: 8723531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease.
    Hoogsteden HC; van Dongen JJ; van Hal PT; Delahaye M; Hop W; Hilvering C
    Chest; 1989 Mar; 95(3):574-7. PubMed ID: 2920586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxygen radical production by alveolar macrophages in sarcoidosis in relation to activity status of bronchoalveolar lavage lymphocytes].
    Strausz J; Müller-Quernheim J; Steppling H; Nagel M; Ferlinz R
    Pneumologie; 1990 Feb; 44 Suppl 1():222-3. PubMed ID: 2367371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis.
    Bäumer I; Zissel G; Schlaak M; Müller-Quernheim J
    Lung; 1997; 175(2):105-16. PubMed ID: 9042667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell distribution and macrophage function in bronchoalveolar lavage of patients with sarcoidosis and lung tumors].
    Klein M; Dietrich U; Claus R; Nausch M; Zingler C; Diwok K
    Z Erkr Atmungsorgane; 1987; 169(3):291-2. PubMed ID: 2833039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAL neopterin : a novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer.
    Mohamed KH; Mobasher AA; Yousef AR; Salah A; El-Naggar IZ; Ghoneim AH; Light RW
    Chest; 2001 Mar; 119(3):776-80. PubMed ID: 11243956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A dependent cell-mediated cytotoxicity (CDCMC) in bronchoalveolar lavage (BAL) fluid of patients with interstitial lung diseases (ILD). Evidence of cytolytic T-lymphocyte (CTL) activity.
    Norin A; Karpel J; Fleitman J; Kamholz S; Pinsker K
    Chest; 1986 Mar; 89(3 Suppl):144S-145S. PubMed ID: 3948576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunopathogenesis of sarcoidosis: current practical knowledge].
    Müller-Quernheim J
    Z Gesamte Inn Med; 1990 Oct; 45(19):573-7. PubMed ID: 2151549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases.
    Casale TB; Trapp S; Zehr B; Hunninghake GW
    Am Rev Respir Dis; 1988 Dec; 138(6):1604-8. PubMed ID: 3202511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis.
    Pueringer RJ; Schwartz DA; Dayton CS; Gilbert SR; Hunninghake GW
    Chest; 1993 Mar; 103(3):832-8. PubMed ID: 8449077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary neopterin in pulmonary sarcoidosis. Relationship to clinical and biologic assessment of the disease.
    Lacronique J; Auzeby A; Valeyre D; Traore BM; Barbosa ML; Soler P; Choudat D; Battesti JP; Touitou Y; Marsac J
    Am Rev Respir Dis; 1989 Jun; 139(6):1474-8. PubMed ID: 2543248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopathology of cytomegalovirus pneumonia and allograft rejection in lung transplantation. Group of Pulmonary Transplantation of the University Paris-Sud].
    Humbert M; Emilie D
    Rev Mal Respir; 1994; 11(6):559-64. PubMed ID: 7831505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
    Haslam PL; Parker DJ; Townsend PJ
    Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?
    Meliconi R; Lalli E; Borzì RM; Sturani C; Galavotti V; Gunella G; Miniero R; Facchini A; Gasbarrini G
    Thorax; 1990 Jul; 45(7):536-40. PubMed ID: 2118691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.